护理干预对氧喷治疗慢性阻塞性肺病急性发作的效果观察被引量：2

Effect of nursing intervention on oxygen spray treatment for chronic obstructive pulmonary disease with acute exacerbation

下载PDF

导出

摘要目的探讨氧气驱动雾化吸入(氧喷)复方异丙托溴铵治疗慢性阻塞性肺病急性发作的护理效果。方法采用随机的方法将86例慢性阻塞性肺病急性发作均采用氧喷复方异丙托溴铵治疗的患者分成两组,每组43例,对照组采取常规护理的方法,而干预组在常规护理基础上进行整体护理。1周后对护理结果进行评价。结果干预组在临床症状评分、肺功能指标和动脉血气指标与对照组比较存在统计学差异(P<0.05)。结论采用氧喷复方异丙托溴铵的方法加上良好的护理方式,对慢性阻塞性肺病急性发作的治疗有较好的临床疗效。 Objective To explore the effect of nursing intervention on the inhalation of compound lpratropium bromide with oxygen-driven nebulizer（oxygen spray） for chronic obstructive pulmonary disease（COPD） with acute exacerbation.Methods A total of 86 COPD patients with acute exacerbation who had inhalation of compound lpratropium bromide with oxygen-driven nebulizer were equally divided into two groups by random selection.The conventional nursing was applied to the control group and the integrative nursing model was applied to the intervention group.After one week,the nursing outcomes were assessed.Results Compared with the control group,clinical symptom score,pulmonary function and arterial blood gas indicators in the intervention group were significantly different（P0.05）.Conclusion The combination of inhalation of compound lpratropium bromide with oxygen-driven nebulizer and integrative nursing mode can achieve better clinical outcomes for COPD patients with acute exacerbation.

作者余月娟陈月华纪静娴

机构地区江苏省东台市人民医院呼吸内科

出处《实用临床医药杂志》 CAS 2012年第8期21-22,25,共3页 Journal of Clinical Medicine in Practice

关键词氧气驱动雾化复方异丙托溴铵慢性阻塞性肺病护理干预 oxygen-driven nebulizer compound lpratropium bromide chronic obstructive pulmonary disease nursing intervention

分类号 R472.2 [医药卫生—急诊医学]

引文网络
相关文献

参考文献9

1谢永平,龚衍,吴瑞明.沐舒坦雾化吸入治疗慢性阻塞性肺病急性加重期患者的疗效观察及护理[J].护士进修杂志,2009,24(15):1437-1438. 被引量：14
2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量：8235
3Zhong N, Wang C, Yao W, et al. Prevalence of chronic ob- structive pulmonary diseases in China; a large population- based survey[J]. Respir Crit Care Med, 2007, 175: 753.
4Wedzicha J A, Calverley P M, Seemungal T A, et al. The prevention of chronic obstructive pulmonary disease exacerba- tions by salmeterol/flution - casone propionate or tiltopium bromide[J]. Am J Respir Crit Care Med, 2008, 177: 19.
5Wise R A, Tashkin D P. Optimizing treatment of chronic ob- structive pulmonary disease: an assessment of current therapies [J]. AmJ Med, 2007, 120:S4.
6Fitzgerald M F, Fox J C. Emerging trends in the therapy of COPD: bronchodilators as mono - and combination therapies [J]. Drug Discovery Today, 2007, 12: 472.
7李晓宇.慢性阻塞性肺病的健康教育和护理指导[J].中国医药指南,2011,9(22):169-170. 被引量：2
8夏斌,周阿旺.布地奈德和复方异丙托溴铵联合雾化吸入治疗慢性阻塞性肺病急性发作期的疗效[J].中国现代医生,2010,48(26):38-39. 被引量：16
9王荣琴.侧卧位氧气雾化吸入治疗在慢性阻塞性肺病急性期的疗效观察[J].临床护理杂志,2011,10(2):25-26. 被引量：5

二级参考文献21

1金一淑,金一南.可必特雾化吸入治疗COPD30例[J].临床肺科杂志,2005,10(6):792-792. 被引量：23
2刘洪君,姚翠玲,许占英,任立新.呼吸操对慢性阻塞性肺病患者肺功能及血气的影响[J].临床肺科杂志,2006,11(1):63-64. 被引量：70
3有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量：279
4武淑萍,谈燕聪.老年慢性阻塞性肺疾病患者急性发作期雾化吸入方式的选择及护理[J].中国全科医学,2006,9(23):1944-1946. 被引量：28
5Vaghi A,Berg E,Liljedahl S,et al. In vitro comparison of nebulised budesonide(Pulmicort Respules)and beclomethasone dipropionate(Clenilper Aerosol)[J]. Pulm Pharmacol Ther,2005,18(2) : 151-153.
6Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2002,165 ( 5 ) : 698-703.
7Ikeda A,Nishimura K,Koyama H,et al. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD:comparison with ipratropium bromide alone[J]. Chest, 1995,107(2) :401-405.
8Oga T,Nishimura K,Tsukino M,et al. A comparison of the effects of salbutarnol and ipratropium bromide on exercise endurance in patients with COPD[J]. Chest, 2003,123(6) : 1810-1816.
9金大鹏,朱宗涵.全科医师实用手册[M].北京:中央广播电视大学出版社,2000:59-60.
10GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.